bioMérieux, a world leader in the field of in vitro diagnostics, today announced it has received international recognition for two new solutions that will help protect consumers from food-borne illnesses.
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2011.
bioMerieux shares new diagnostic tools at the 49th Annual Meeting of the Infectious Diseases Society of America - visit IDSA booth #916
The Board of Directors of bioMerieux, a world leader in the field of in vitro diagnostics, met today to approve the consolidated financial statements for the six months ended June 30, 2011. The meeting was chaired by Jean-Luc Belingard and attended by the Statutory Auditors, who had performed a limited review of the financial statements.
bioMérieux has today acquired the entire capital and voting rights of Skiva (441 886 728 R.C.S. Paris), the parent company of the AES Chemunex group.
bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has acquired ARGENE, a French company specialized in molecular diagnostics. This acquisition is bioMérieux’s tenth in the last five years.
bioMerieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2011.
VIDAS® UP Recombinant Phage Technology Delivers Unprecedented Specificity and Sensitivity for Rapid and Reliable Testing
The International Association for Food Protection (IAFP) selected bioMerieux, Inc., as the 2011 recipient of the prestigious Black Pearl Award. Sponsored by Wilbur Feagan and F & H Food Equipment Company, the Black Pearl Award will be presented at IAFP's Annual Meeting in Milwaukee, Wisconsin in August.
AOAC Official Methods(SM) Approval Underscores VIDAS® Excellence in Food Safety Testing
